Invention Grant
- Patent Title: Perhexiline for treating chronic heart failure
- Patent Title (中): Perhexiline治疗慢性心力衰竭
-
Application No.: US13841465Application Date: 2013-03-15
-
Publication No.: US08697677B2Publication Date: 2014-04-15
- Inventor: Michael Paul Frenneaux
- Applicant: Heart Metabolics Limited
- Applicant Address: GB London
- Assignee: Heart Metabolics Limited
- Current Assignee: Heart Metabolics Limited
- Current Assignee Address: GB London
- Agency: Nixon & Vanderhye P.C.
- Priority: GB0405381.5 20040310
- Main IPC: A61K31/56
- IPC: A61K31/56 ; A61K31/415

Abstract:
Disclosed are methods for the treatment of chronic heart failure, comprising administering to an animal in need thereof an effective amount of perhexiline, or a pharmaceutically acceptable salt thereof, to treat said chronic heart failure. The chronic heart failure maybe non-ischaemic or ischaemic. Also disclosed is the use of perhexiline in the manufacture of a medicament to treat chronic heart failure, including chronic heart failure of a non-ischaemic origin and chronic heart failure of an ischaemic origin.
Public/Granted literature
- US20130224118A1 PERHEXILINE FOR TREATING CHRONIC HEART FAILURE Public/Granted day:2013-08-29
Information query